Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients
- PMID: 16569895
- PMCID: PMC1426936
- DOI: 10.1128/AAC.50.4.1599-1602.2006
Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients
Abstract
We assessed the toxicity and clinical outcomes associated with linezolid therapy (mean duration, 29+/-28 days; range, 8 to 185 days) in 44 patients with serious gram-positive infections. Although a clinical cure was achieved in 73% of the cases, 28/44 (64%) had adverse reactions (thrombocytopenia, n=13; anemia, n=7; gastrointestinal, n=12; peripheral neuropathy, n=1; serotonin syndrome, n=1), such that a systematic monitoring protocol was developed.
References
-
- Apodaca, A. A., and R. M. Rakita. 2003. Linezolid-induced lactic acidosis. N. Engl. J. Med. 348:86-87. - PubMed
-
- Atassi, K., E. Hershberger, R. Alan, and M. J. Zervas. 2002. Thrombocytopenia associated with linezolid therapy. Clin. Infect. Dis. 34:695-698. - PubMed
-
- Bernard, L., R. Stern, D. Lew, and P. Hoffmeyer. 2003. Serotonin syndrome after concomitant treatment with linezolid and citalopram. Clin. Infect. Dis. 36:1197. - PubMed
-
- Birmingham, M. C., C. R. Rayner, A. K. Meagher, S. M. Flavin, D. H. Batts, and J. J. Schentag. 2003. Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. Clin. Infect. Dis. 36:159-168. - PubMed
-
- Diekema, D. J., and R. N. Jones. 2001. Oxazolidinone antibiotics. Lancet 358:1975-1982. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
